Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
19.83 USD | -0.10% | +4.81% | -27.92% |
Apr. 15 | Goldman Sachs Cuts Veracyte Price Target to $28 From $32, Maintains Buy Rating | MT |
Feb. 26 | Morgan Stanley Trims Veracyte's Price Target to $21 From $22, Keeps Underweight Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-27.92% | 1.49B | |
-14.13% | 11.33B | |
+45.76% | 3.16B | |
-35.86% | 2.14B | |
-18.27% | 2.04B | |
+18.02% | 975M | |
-3.49% | 731M | |
-31.42% | 423M | |
+26.64% | 371M | |
-47.55% | 364M |
- Stock Market
- Equities
- VCYT Stock
- News Veracyte, Inc.
- SVB Securities Adjusts Veracyte's Price Target to $35 From $30, Keeps Outperform Rating